Invitro International
InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivi… Read more
Invitro International (IVRO) - Total Assets
Latest total assets as of March 2024: $1.58 Million USD
Based on the latest financial reports, Invitro International (IVRO) holds total assets worth $1.58 Million USD as of March 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Invitro International - Total Assets Trend (1989–2023)
This chart illustrates how Invitro International’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Invitro International - Asset Composition Analysis
Current Asset Composition (September 2023)
Invitro International's total assets of $1.58 Million consist of 95.6% current assets and 4.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 23.3% |
| Accounts Receivable | $96.61K | 6.3% |
| Inventory | $163.13K | 10.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $7.57K | 0.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1989–2023)
This chart illustrates how Invitro International's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Invitro International's current assets represent 95.6% of total assets in 2023, an increase from 88.9% in 1989.
- Cash Position: Cash and equivalents constituted 23.3% of total assets in 2023, down from 44.4% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1989.
- Asset Diversification: The largest asset category is inventory at 10.6% of total assets.
Invitro International Competitors by Total Assets
Key competitors of Invitro International based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Invitro International - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Invitro International generates 0.52x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Invitro International generates $ 0.10 in net profit.
Invitro International - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 27.85 | 31.13 | 4.20 |
| Quick Ratio | 24.36 | 27.81 | 2.26 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.48 Million | $ 1.38 Million | $ 829.00K |
Invitro International - Advanced Valuation Insights
This section examines the relationship between Invitro International's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 1.6% |
| Total Assets | $1.53 Million |
| Market Capitalization | $816.93 USD |
Valuation Analysis
Below Book Valuation: The market values Invitro International's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Invitro International's assets grew by 1.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Invitro International (1989–2023)
The table below shows the annual total assets of Invitro International from 1989 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-09-30 | $1.53 Million | +1.59% |
| 2022-09-30 | $1.51 Million | -7.47% |
| 2021-09-30 | $1.63 Million | +6.03% |
| 2020-09-30 | $1.54 Million | +11.54% |
| 2019-09-30 | $1.38 Million | +18.88% |
| 2017-09-30 | $1.16 Million | +99.28% |
| 2008-09-30 | $582.43K | +15.82% |
| 2007-09-30 | $502.87K | -79.05% |
| 1996-09-30 | $2.40 Million | -25.00% |
| 1995-09-30 | $3.20 Million | -50.77% |
| 1994-09-30 | $6.50 Million | +20.37% |
| 1993-09-30 | $5.40 Million | +125.00% |
| 1992-09-30 | $2.40 Million | -61.90% |
| 1991-09-30 | $6.30 Million | +173.91% |
| 1990-09-30 | $2.30 Million | +155.56% |
| 1989-09-30 | $900.00K | -- |